WCLC 2022 Conference Coverage
Playback speed
10 seconds
WCLC 2022 on the ADAURA2 Phase III Study: Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFRm NSCLC
By
WCLC 2022 Conference Coverage
FEATURING
Toon van der Gronde
By
WCLC 2022 Conference Coverage
FEATURING
Toon van der Gronde
63 views
September 7, 2022
Comments 0
Login to view comments.
Click here to Login
Videos